Medical Facilities Corporation (TSX:DR)
Canada · Delayed Price · Currency is CAD 16.95
+0.01 (0.06%)
Nov 13, 2026, 4:00 PM EST
Medical Facilities Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 248.61 | 254.17 | 246.09 | 339.58 | 424.55 | 398.63 | |
Revenue Growth | 19.96% | 3.28% | -27.53% | -20.02% | 6.50% | 9.56% |
Cost of Revenue | 139.72 | 145.93 | 138.69 | 209.31 | 271.28 | 249.93 |
Gross Profit | 108.9 | 108.24 | 107.4 | 130.26 | 153.27 | 148.71 |
Selling, General & Admin | 49.37 | 49.85 | 50.84 | 62.78 | 70.86 | 57.68 |
Amortization of Goodwill & Intangibles | 0.54 | 0.54 | 0.54 | 1.31 | 0.64 | 7.23 |
Operating Expenses | 60.16 | 61.58 | 62.31 | 81.09 | 91.62 | 84.45 |
Operating Income | 48.74 | 46.66 | 45.09 | 49.18 | 61.65 | 64.26 |
Interest Expense | -6.88 | -8.7 | -11.68 | -13.25 | -12.89 | -14.2 |
Interest & Investment Income | 0.28 | 2.21 | 1.08 | 0.72 | 0.32 | 0.08 |
Earnings From Equity Investments | - | - | - | -0.32 | -0.57 | -0.13 |
Currency Exchange Gain (Loss) | 0.06 | -0.17 | -0.06 | -0.03 | -0 | -0.03 |
Other Non Operating Income (Expenses) | 6.21 | -0.41 | 0.54 | -3.08 | 7.7 | -12.19 |
EBT Excluding Unusual Items | 48.4 | 39.59 | 34.97 | 33.21 | 56.2 | 37.79 |
Impairment of Goodwill | - | - | - | - | -15.36 | - |
Gain (Loss) on Sale of Assets | - | - | - | 2.49 | - | - |
Asset Writedown | - | - | - | - | -1.19 | - |
Other Unusual Items | - | - | 7.29 | -0.79 | -22.15 | 13.1 |
Pretax Income | 48.4 | 39.59 | 42.25 | 34.91 | 17.5 | 50.89 |
Income Tax Expense | 8.73 | 4.97 | -6.01 | 6.06 | 5.21 | 4.4 |
Earnings From Continuing Operations | 39.68 | 34.62 | 48.27 | 28.85 | 12.3 | 46.49 |
Earnings From Discontinued Operations | 21.29 | 9.8 | 57.3 | 15.15 | - | - |
Net Income to Company | 60.96 | 44.42 | 105.56 | 44 | 12.3 | 46.49 |
Minority Interest in Earnings | -22.09 | -23.16 | -32.07 | -25.5 | -16.7 | -30.99 |
Net Income | 38.87 | 21.26 | 73.49 | 18.5 | -4.41 | 15.5 |
Net Income to Common | 38.87 | 21.26 | 73.49 | 18.5 | -4.41 | 15.5 |
Net Income Growth | -52.21% | -71.08% | 297.18% | - | - | 75.88% |
Shares Outstanding (Basic) | 17 | 19 | 24 | 25 | 29 | 31 |
Shares Outstanding (Diluted) | 21 | 19 | 24 | 25 | 29 | 31 |
Shares Change | -4.02% | -18.83% | -4.96% | -14.00% | -5.65% | 0.07% |
EPS (Basic) | 2.26 | 1.09 | 3.06 | 0.73 | -0.15 | 0.50 |
EPS (Diluted) | 2.01 | 1.09 | 3.06 | 0.73 | -0.15 | 0.50 |
EPS Growth | -44.45% | -64.38% | 319.18% | - | - | 78.04% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 44 | 40.28 | 76.22 | 56.66 | 50.3 | 67.22 |
Free Cash Flow Per Share | 2.12 | 2.07 | 3.18 | 2.24 | 1.71 | 2.16 |
Dividend Per Share | 0.066 | 0.263 | 0.241 | 0.242 | 0.238 | 0.230 |
Dividend Growth | -73.07% | 8.87% | -0.47% | 1.85% | 3.64% | 4.46% |
Gross Margin | 43.80% | 42.59% | 43.64% | 38.36% | 36.10% | 37.30% |
Operating Margin | 19.61% | 18.36% | 18.32% | 14.48% | 14.52% | 16.12% |
Profit Margin | 15.63% | 8.36% | 29.86% | 5.45% | -1.04% | 3.89% |
Free Cash Flow Margin | 17.70% | 15.85% | 30.97% | 16.69% | 11.85% | 16.86% |
EBITDA | 54.85 | 53.12 | 54.21 | 60.01 | 71.58 | 80.86 |
EBITDA Margin | 22.06% | 20.90% | 22.03% | 17.67% | 16.86% | 20.28% |
D&A For EBITDA | 6.11 | 6.46 | 9.12 | 10.84 | 9.93 | 16.6 |
EBIT | 48.74 | 46.66 | 45.09 | 49.18 | 61.65 | 64.26 |
EBIT Margin | 19.61% | 18.36% | 18.32% | 14.48% | 14.52% | 16.12% |
Effective Tax Rate | 18.03% | 12.56% | - | 17.37% | 29.75% | 8.64% |
Revenue as Reported | 248.61 | 254.17 | 253.37 | 339.58 | 414.39 | 411.73 |